GlycoMimetics Stock Price (NASDAQ:GLYC)

Add to My Stocks
$13.25 $2.24 (20.35%) GLYC stock closing price May 23, 2017 (Closing)
Prev Close* : $11.01
Market Cap:
$271.29M
Day Low: $10.26
52 Week Low: $3.82
Open: $11
Volume: 13144803
Day High: $14.3
52 Week High: $14.64
Dividend:
N/A

Latest Stock Market News

Latest Articles

GlycoMimetics News - From Partners

GLYC Stockcharts

View GLYC PE ratio, PS ratio stocks charts and compare with peers.
GLYC Chart
Note: Compare GlycoMimetics stock price history with the index and industry peers.

GLYC Industry Peers

Company Price Change (%)
Arrowhead Pharma (ARWR)1.640 (0%)
Vernalis (VNLPY)0.580 (0%)
Global Blood Therapeutics (GBT)28.951.05 (3.5%)
Pfizer (PFE)32.140.02 (0.06%)
Sangamo Biosciences (SGMO)8.20.75 (10.07%)
Bluebird Bio (BLUE)80.351.4 (1.77%)
Emisphere Tech (EMIS)0.450.02 (4.26%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
GlycoMimetics (GLYC)13.252.24 (20.35%)
Endo International (ENDP)12.881.04 (8.78%)
Achaogen (AKAO)26.080.9 (3.57%)
Nature's Sunshine Products (NATR)11.80.35 (3.06%)
Adamis Pharma (ADMP)4.050.1 (2.53%)
Nektar Therapeutics (NKTR)19.750.47 (2.44%)
Flexion Therapeutics (FLXN)19.590.4 (2.08%)
Top gainers from Medical-Drugs industry
* As of May 24, 2017
CompanyPriceChange (%)
La Jolla Pharma (LJPC)31.921.78 (5.28%)
Synergy Pharma (SGYP)3.770.16 (4.07%)
Taro Pharma (TARO)107.94.42 (3.94%)
ImmunoGen (IMGN)4.980.18 (3.49%)
Zogenix (ZGNX)12.750.35 (2.67%)
Karyopharm Therapeutics (KPTI)9.530.25 (2.56%)
Esperion Therapeutics (ESPR)32.970.79 (2.34%)
Top losers from Medical-Drugs industry
* As of May 24, 2017

GlycoMimetics Inc Stock News - Partner Headlines

GlycoMimetics Financial Statements

income statement20162015201420132012
Net Sales Or Revenues0.01M20.07M15.02M3.99M15.25M
Net Income-31.8M-12.76M-11.12M-10.6M3.65M
Total Operating Expense31.93M32.85M26.16M14.58M11.58M
view GlycoMimetics Inc income statement
balance sheet20162015201420132012
Total Assets42.38M48.46M57.26M5.28M18.41M
Total Liabilities7.08M7.99M6.46M2.37M5.89M
Shareholders Equity35.3M40.47M50.8M2.9M12.52M
view GlycoMimetics Inc balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-1.07M2M5.04M-5.49M-14.64M
Net Cash From (Used By) Operating Activities-29.73M-8.24M-4.28M-15.53M-10.47M
Increase (Decrease) In Prop Plant And Equipment-0.7M-0.26M-0.21M-0.08M-0.31M
view GlycoMimetics Inc cashflow statement

GlycoMimetics Stock Message Board

GlycoMimetics stock price ended the last trading day at 13.25. GlycoMimetics market capitalization is 271.29M and it represents the total market value of GLYC stock. A value investor must look at the fundamentals of a stock, and perform GlycoMimetics valuation, even though in the short-term sentiment and current breaking news might affect GlycoMimetics stock price.

For recognizing and analyzing the real performance of GlycoMimetics stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume number in GlycoMimetics stock quote data shows the number of shares traded. For Ex: 13144803 GlycoMimetics shares were traded as of last trading day, as seen from GlycoMimetics stock chart. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. To check the historical stock price movement, all time high, and all time low of GLYC, view GlycoMimetics stock price history.